 2
Abstract 
 
Oxidized low density lipoprotein (oxLDL) is a risk factor for atherosclerosis. However, 
the cholesterol screening alone is not a good indicator for the progress of atherosclerosis. 
Recently, C reactive protein (CRP) is reported to be a good predictor for the progress of 
atherosclerosis and can bind to oxidized phosphocholine in oxLDL. Therefore, the 
combination of oxLDL and CRP levels may become a more reliable predictor for future 
cardiovascular events. This study was focused on the effect of oxLDL/CRP complex on nitric 
oxide (NO) production in human aortic endothelial cells. We found that oxLDL and CRP both 
decreased NO production and eNOS protein expression. A molar ratio oxLDL:CRP ~ 4.5:1 
resulted in a synergic reduction of NO release whereas other ratios have less effect. On the 
other hand, both of Anti-CD36 and Anti-CRP could only partially restore NO release in 
oxLDL/CRP treated cells, indicating that there is another pathway to affect the endothelial 
function by the complex of oxLDL/CRP.   
 
Keywords: low density lipoprotein, c-reactive protein, nitric oxide, endothelial cells 
 
 4
????? CRP ??????????? NO ?????? 17,18??????????
??????? CRP ????????????????????????????
????CRP ???????????????????????????? Fc??a
?? Fc?-R ????CRP ??? Fc??a ????? 19???? IgG ??? Fc?-R ?
???????? CRP ? IgG ??????????????????? 
? oxLDL ?????????? Akt ????????Akt ??????? eNOS?
????? NO ??????? oxLDL ???????????????? NO ???
??????????(??? NO ??????)????? Akt ?????????
???????????????????? 20?????????? oxLDL ?? NO
????????? eNOS ????????????????????? eNOS ??
?? 21???????? eNOS mRNA ???????? eNOS ??????????
??????????????? CRP ?????? NO ????????? CRP ?
??????????????????????? CRP ????????????
?? eNOS mRNA ?? eNOS ???????? 22,23? 
??????oxLDL ? CRP ???? eNOS mRNA ?????? NO ?????
??????????oxLDL ? CRP ????????? oxLDL/CRP ???????
??????????????????????????????? 
 
???? 
 
????????????? 
???? 
DPBS: ??? DPBS ???? 1 L ?????? 900 mL ??????? 1 N HCl ? 1 N 
NaOH ??? 25? pH ?? 7.4???? DPBS ?????? 1 L? 
???: 8 mL ?????1 mL 100 U/mL penicillin-100?g /mL streptomycin-0.25?g/mL 
amphotericin B?0.5 mL 10mg/mL, gentamicin solution?4 mL low serum growth factor??
? Medium-200 100mL ??????????? 10 %????? 
???: 90 % ????10 % steril DMSO? 
Trypsin-EDTA (1X): 10 % Trypsin-EDTA (10x)?90 % DPBS? 
Gelatin Solution: 1.5 g Gelatin?100 mL ??????????????? 
???? 
???(60 ? 15 mm)??? 1.2 mL ? gelatin????? 37 ????? 15 ???
??????????????? gelatin????? 3 mL ? DPBS????????
???????????????????????? 1 mL ????????????
????? 2 mL ?????????????????????? 37 ? CO2 ???
???????? 2 ?????????????? 4 ??????? 
 
LDL ???-?????????? 
???? 
Stock salt solution: ???????153 g????354 g??????????1.346? 
??????: ??????0.15 M?????????????1.005? 
??(whole blood)??: ?????? 
LDL???? 
??KBr (1.346) ? NaCl (1.005)??????????????A ? 1.005 + B ? 
1.346 = (A+B) ? X???A?0.15 M???=1.005 g/mL NaCl???B????????
??????1.346 g/mL?X ???????? 
 
 6
 
CRP ??? 
???? 
Sodium deoxycholate: ???? 1 wt%??????????????? 
?? C reactive protein ???????: ?? NaCl 140 mM?20 mM Tris-HCl?2 mM 
CaCl2????? pH ?? 7.4~7.5? 
???? 
????:????? 20~25 mL ?? column (Detoxi-Gel-Endotoxin Removing 
Gel)????? 20~25 mL 1 % Sodium deoxycholate ????????? 20~25 mL ??
? column?????????????????? gel ?? column ????????
? gel ???????????????????? 1 mL ??? gel ???????
column ????????????????????????? 4 ?????? 1 ??
? gel ????????column ?????? gel ??????????? 1 % sodium 
deoxycholate (20~25 mL)??????????????????(20~25 mL)?????
??????????????? CRP?? 1 mL CRP ???? column ?????? 1 
mL gel??? 0.3~0.5 mL????????? gel ?? 4 mL???????? 1.2~2.0 mL
????????? CRP ??? 20 ???? tube????? CRP ????? 0.2 mL?
????????? BCA protein assay ?????????????????????
??????????????????????????????????????
??????????????????????????? column ??? 1 % sodium 
deoxycholate (12~20 mL)????? 5 ???????????????????(12~20 
mL)???? gel ????????? 4 ?? 
 
 
????? 
 
?? 1 ?? oxLDL ? CRP ??????? NO ??????? oxLDL ? CRP ?
??????????????? oxLDL/CRP ? NO ????????????oxLDL 
20 ?g/mL?CRP 1 ?g/mL (oxLDL ? apoB-100 ?????? 510 KD?? CRP ???
?? 115 KD??? oxLDL?CRP ?????? 20/510?1/115 = 4.5?1) ? NO ???
???? oxLDL ? CRP ??????????????????????oxLDL/CRP
????? oxLDL ????????????????????????? NO ??
??? CRP ??????oxLDL 20 ?g/mL?CRP 5 ?g/mL NO ??????????
????? oxLDL ??????????????? oxLDL?CRP ??????? 4?
5???? CRP ??????????????????????? NO ???????
? CRP ????? 10 ?g/mL?????????????? Nitrite ???????
?? oxLDL 100 ?g/mL?CRP 1 ?g/mL ????oxLDL ?????????????
?? CRP ???????????????????? NO ???????????
oxLDL 100 ?g/mL?CRP 5 ?g/mL??? oxLDL?CRP ?????? 4.5?1????
?? CRP ? oxLDL ??????????????????????????? NO
??????????????????????????? oxLDL ? CRP ????
?????????????? 
?? anti-CRP ? anti-CD36 ??? oxLDL/CRP ???????????????
? 2 ????????? NO ???????????? oxLDL?CRP ??????
4.5?1 ??oxLDL/CRP ????????????????????? anti-CD36 ?
anti-CRP ???? oxLDL 20 ?g/mL?CRP 1 ?g/mL ??????????????
?????? Nitrite ?????????????? oxLDL/CRP ?????????
 8
protein-protein interactions in NO/cGMP signaling. Proc. Natl. Acad. Sci. U S A. 2002?
99(26)?16510-16512 
12.  Tillet, W. S., Francis, T. Serological reactions in pneumonia with a non-protein somatic 
fraction of the pneumococcus. J. Exp. Med. 1930?52?567-571 
13.  Hulthe J., Wikstrand J., Fagerberg B. Relationship between C-reactive protein and 
intima-media thickness in the carotid and femoral arteries and to antibodies against 
oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin 
Resistance (AIR) study. Clin. Sci. 2001?100(4)?371-378 
14.  Verma S., Li S. H., Badiwala M. V., Weisel R. D., Fedak P. W., Li R. K., Dhillon B., 
Mickle D. A. Endothelin antagonism and interleukin-6 inhibition attenuate the 
proatherogenic effects of C-reactive protein. Circulation. 2002?105(16)?1890-1896 
15.  Ablij H., Meinders A. C-reactive protein: history and revival. Eur. J. Intern. Med. 2002?
13(7)?412-422 
16.  Fichtlscherer S., Rosenberger G., Walter D. H., Breuer S., Dimmeler S., Zeiher A. M. 
Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with 
coronary artery disease. Circulation. 2000?102(9)?1000-1006 
17.  Verma S, Wang C. H., Li S. H., Dumont A. S., Fedak P. W., Badiwala M. V., Dhillon B., 
Weisel R. D., Li R. K., Mickle D. A., Stewart D. J. A self-fulfilling prophecy: C-reactive 
protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002?
106(8)?913-919 
18.  Venugopal S. K., Devaraj S., Yuhanna I., Shaul P., Jialal I. Demonstration that C-reactive 
protein decreases eNOS expression and bioactivity in human aortic endothelial cells. 
Circulation. 2002?106(12)?1439-1441 
19.  Stein M. P., Edberg J. C., Kimberly R. P., Mangan E. K., Bharadwaj D., Mold C., Du 
Clos T. W. C-reactive protein binding to FcgammaRIIa on human monocytes and 
neutrophils is allele-specific. J. Clin. Invest. 2000?105(3)?369-376 
20. Goetze S., Bungenstock A., Czupalla C., Eilers F., Stawowy P., Kintscher U., 
Spencer-Hansch C., Graf K., Nurnberg B., Law R. E., Fleck E., Grafe M. Leptin induces 
endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. 
Hypertension. 2002?40(5)?748-754 
21.  Blair A., Shaul P. W., Yuhanna I. S., Conrad P. A., Smart E. J. Oxidized low density 
lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal 
caveolae and impairs eNOS activation. J. Biol. Chem. 1999?274(45)?32512-32519 
22.  Venugopal S. K., Devaraj S., Yuhanna I., Shaul P., Jialal I. Demonstration that 
C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial 
cells. Circulation. 2002?106(12)?1439-1441 
23.  Verma S., Kuliszewski M. A., Li S. H., Szmitko P. E., Zucco L., Wang C. H., Badiwala 
M. V., Mickle D. A., Weisel R. D., Fedak P. W., Stewart D. J., Kutryk M. J. C-reactive 
protein attenuates endothelial progenitor cell survival, differentiation, and function: further 
evidence of a mechanistic link between C-reactive protein and cardiovascular disease. 
Circulation. 2004?109(17)?2058-2067 
